受强制性开放获取政策约束的文章 - Marcia Hall了解详情
无法在其他位置公开访问的文章：1 篇
A phase 2 study of anastrozole in patients with oestrogen receptor and/progesterone receptor positive recurrent/metastatic granulosa cell tumours/sex-cord stromal tumours of …
SN Banerjee, M Tang, RL O'Connell, K Sjoquist, AR Clamp, D Millan, ...
Gynecologic Oncology 163 (1), 72-78, 2021
强制性开放获取政策： Cancer Research UK
可在其他位置公开访问的文章：37 篇
Copy number signatures and mutational processes in ovarian carcinoma
G Macintyre, TE Goranova, D De Silva, D Ennis, AM Piskorz, M Eldridge, ...
Nature genetics 50 (9), 1262-1270, 2018
强制性开放获取政策： Cancer Research UK, UK Medical Research Council, National Institute for …
First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE …
HS Wasan, P Gibbs, NK Sharma, J Taieb, V Heinemann, J Ricke, ...
The Lancet Oncology 18 (9), 1159-1171, 2017
强制性开放获取政策： Cancer Research UK, National Institute for Health Research, UK
Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials
I Vergote, C Coens, M Nankivell, GB Kristensen, MKB Parmar, T Ehlen, ...
The Lancet Oncology 19 (12), 1680-1687, 2018
强制性开放获取政策： US National Institutes of Health, Cancer Research UK, UK Medical Research …
Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): long-term results of a multicentre, randomised, controlled …
JA Bridgewater, SA Pugh, T Maishman, Z Eminton, J Mellor, A Whitehead, ...
The lancet oncology 21 (3), 398-411, 2020
强制性开放获取政策： Cancer Research UK, UK Medical Research Council, National Institute for …
Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis …
AR Clamp, EC James, IA McNeish, A Dean, JW Kim, DM O'Donnell, ...
The Lancet 394 (10214), 2084-2095, 2019
强制性开放获取政策： Health Research Board, Ireland, Cancer Research UK, UK Medical Research Council
A randomised, placebo-controlled trial of weekly paclitaxel and saracatinib (AZD0530) in platinum-resistant ovarian, fallopian tube or primary peritoneal cancer
IA McNeish, JA Ledermann, L Webber, L James, SB Kaye, M Hall, G Hall, ...
Annals of oncology 25 (10), 1988-1995, 2014
强制性开放获取政策： Cancer Research UK, UK Medical Research Council
Bevacizumab with peri-operative epirubicin, cisplatin and capecitabine (ECX) in localised gastro-oesophageal adenocarcinoma: a safety report
AFC Okines, RE Langley, LC Thompson, SP Stenning, L Stevenson, ...
Annals of oncology 24 (3), 702-709, 2013
强制性开放获取政策： Cancer Research UK
OV21/PETROC: a randomized Gynecologic Cancer Intergroup phase II study of intraperitoneal versus intravenous chemotherapy following neoadjuvant chemotherapy and optimal …
DM Provencher, CJ Gallagher, WR Parulekar, JA Ledermann, ...
Annals of Oncology 29 (2), 431-438, 2018
强制性开放获取政策： US National Institutes of Health, Canadian Cancer Society, Cancer Research …
Phase 2 study of anastrozole in recurrent estrogen (ER)/progesterone (PR) positive endometrial cancer: The PARAGON trial–ANZGOG 0903
L Mileshkin, R Edmondson, RL O'Connell, KM Sjoquist, J Andrews, ...
Gynecologic Oncology 154 (1), 29-37, 2019
强制性开放获取政策： Research Foundation (Flanders), Cancer Research UK
A multicenter, randomized trial of flat dosing versus intrapatient dose escalation of single-agent carboplatin as first-line chemotherapy for advanced ovarian cancer: an SGCTG …
S Banerjee, G Rustin, J Paul, C Williams, S Pledge, H Gabra, G Skailes, ...
Annals of oncology 24 (3), 679-687, 2013
强制性开放获取政策： Cancer Research UK
Biomarker analysis in oesophagogastric cancer: Results from the REAL3 and TransMAGIC trials
AFC Okines, DG De Castro, D Cunningham, I Chau, RE Langley, ...
European journal of cancer 49 (9), 2116-2125, 2013
强制性开放获取政策： Cancer Research UK, UK Medical Research Council
Phase IB dose escalation and expansion study of AKT inhibitor afuresertib with carboplatin and paclitaxel in recurrent platinum-resistant ovarian cancer
SP Blagden, AL Hamilton, L Mileshkin, S Wong, A Michael, M Hall, ...
Clinical Cancer Research 25 (5), 1472-1478, 2019
强制性开放获取政策： Cancer Research UK
Objective responses to first-line neoadjuvant carboplatin–paclitaxel regimens for ovarian, fallopian tube, or primary peritoneal carcinoma (ICON8): post-hoc exploratory …
RD Morgan, IA McNeish, AD Cook, EC James, R Lord, G Dark, ...
The Lancet Oncology 22 (2), 277-288, 2021
强制性开放获取政策： Health Research Board, Ireland, Cancer Research UK, UK Medical Research …
Bevacizumab and Combination Chemotherapy in rectal cancer Until Surgery (BACCHUS): a phase II, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in …
R Glynne-Jones, N Hava, V Goh, S Bosompem, J Bridgewater, I Chau, ...
BMC cancer 15, 1-10, 2015
强制性开放获取政策： Cancer Research UK, UK Medical Research Council, UK Research & Innovation
Diffusion-weighted MRI in advanced epithelial ovarian cancer: apparent diffusion coefficient as a response marker
JM Winfield, JC Wakefield, D Dolling, M Hall, S Freeman, JD Brenton, ...
Radiology 293 (2), 374-383, 2019
强制性开放获取政策： Cancer Research UK, UK Engineering and Physical Sciences Research Council …
Imaging modality and frequency in surveillance of stage I seminoma testicular cancer: results from a randomized, phase III, noninferiority trial (TRISST)
JK Joffe, FH Cafferty, L Murphy, GJS Rustin, SA Sohaib, R Gabe, ...
Journal of Clinical Oncology 40 (22), 2468-2478, 2022
强制性开放获取政策： Cancer Research UK, UK Medical Research Council, National Institute for …
Weekly platinum-based chemotherapy versus 3-weekly platinum-based chemotherapy for newly diagnosed ovarian cancer (ICON8): quality-of-life results of a phase 3, randomised …
SP Blagden, AD Cook, C Poole, L Howells, IA McNeish, A Dean, JW Kim, ...
The Lancet Oncology 21 (7), 969-977, 2020
强制性开放获取政策： Health Research Board, Ireland, Cancer Research UK, UK Medical Research …
BACCHUS: A randomised non-comparative phase II study of neoadjuvant chemotherapy (NACT) in patients with locally advanced rectal cancer (LARC)
R Glynne-Jones, MR Hall, A Lopes, S Pearce, V Goh, S Bosompem, ...
Heliyon 4 (9), 2018
强制性开放获取政策： Cancer Research UK, UK Medical Research Council, National Institute for …
A phase II randomised, placebo-controlled trial of low dose (metronomic) cyclophosphamide and nintedanib (BIBF1120) in advanced ovarian, fallopian tube or primary peritoneal cancer
MR Hall, HM Dehbi, S Banerjee, R Lord, A Clamp, JA Ledermann, ...
Gynecologic oncology 159 (3), 692-698, 2020
强制性开放获取政策： US National Institutes of Health, Cancer Research UK, National Institute for …
出版信息和资助信息由计算机程序自动确定